3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
5
Recurrence
4
Head and Neck Neoplasms
3
Diffuse Intrinsic Pontine Glioma
3
Glioma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Recurrence of Head and Cancer in Irraiated Area
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Diseases
1
Nasopharyngeal Carcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Brain Stem Neoplasms
1
Interventions
temsirolimus
1
rofecoxib
1
rindopepimut
1
ovex
1
imetelstat
1
entinostat
1
cixutumumab
1
azurin (50-77)
1
Thalidomide
1
Re-Irradiation
1
Piperazine
1
Mebendazole
1
Irinotecan
1
GRN163L peptide
1
Everolimus
1
Dasatinib
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Brain Stem Neoplasms
×
Re-Irradiation
×
Clear all
NCT06093165
2023-10-23
REMIT
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
59 enrolled